The UCLA Heart Transplant Program performed its 2,000th heart transplant surgery earlier this month, becoming the first program in the western United States and only the second in the world to achieve this remarkable milestone.
FDA Warns Praxada May Lead to Severe Internal Bleeding or Heart Failure – San Francisco Chronicle
FDA Warns Praxada May Lead to Severe Internal Bleeding or Heart FailureSan Francisco ChronicleAccording to the FDA's warning, Pradaxa may be likely to cause serious internal bleeding or heart failure that in some cases lead to death. The comprehens…
UCLA Heart Transplant Program performs 2000th heart transplant surgery – News-Medical.net
UCLA Heart Transplant Program performs 2000th heart transplant surgeryNews-Medical.netThe UCLA Heart Transplant Program performed its 2000th heart transplant surgery earlier this month, becoming the first program in the western United States and only t…
Barcelona agree to sign fullback Alba from Valencia
Barcelona have strengthened their defence and found a replacement for Eric Abidal by sealing an agreement with Valencia to sign Spain fullback Jordi Alba on a five-year contract.
TB Treatment Paradox: Mouse Studies Show Body's Own Response Helps TB Bacteria Survive
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center a…
Tour team accused of doping – NEWS.com.au
NEWS.com.auTour team accused of dopingNEWS.com.auThe report said the team were being investigated by French government authorities for the possible use of "intravenous transfusions for recovery and the consumption of banned corticosteroids". …
BioTrends Research GroupPosted on:28 Jun 12 – PharmiWeb.com (press release)
BioTrends Research GroupPosted on:28 Jun 12PharmiWeb.com (press release)In fact, interest in BG-12, along with Biogen Idec‚Äôs PEG-Avonex, Abbott / Biogen Idec‚Äôs daclizumab and Roche / Genentech‚Äôs ocrelizumab, has increased significantl…
French team Europcar play down doping claims – Business Recorder (blog)
French team Europcar play down doping claimsBusiness Recorder (blog)The report said the team were being investigated by French government authorities for the possible use of "intraveinous transfusions for recovery and the consumption of banned cor…
3SBio Secures SFDA Approval To Join Global Phase III Trial For Voclosporin
3SBio Secures SFDA Approval To Join Global Phase III Trial For Voclosporin
Isotechnika Pharma's Partner 3SBio Recieves Approval for Phase 3 Trial of Voclosporin in China
EDMONTON, Alberta — Isotechnika Pharma Inc. ("Isotechnika" or the "Company") announced today that 3SBio Inc. , a leading China-based biotechnology company focused on researching, developing, …